These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29114915)

  • 1. Radiopharmaceuticals for imaging and endoradiotherapy of neurotensin receptor-positive tumors.
    Maschauer S; Prante O
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):309-325. PubMed ID: 29114915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer.
    Hodolic M; Ambrosini V; Fanti S
    Nucl Med Commun; 2020 May; 41(5):411-415. PubMed ID: 32168264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS
    Fanelli R; Chastel A; Previti S; Hindié E; Vimont D; Zanotti-Fregonara P; Fernandez P; Garrigue P; Lamare F; Schollhammer R; Balasse L; Guillet B; Rémond E; Morgat C; Cavelier F
    Bioconjug Chem; 2020 Oct; 31(10):2339-2349. PubMed ID: 32887526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of [
    Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
    Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin analogs by fluoroglycosylation at N
    Schindler L; Wohlfahrt K; Gluhacevic von Krüchten L; Prante O; Keller M; Maschauer S
    Sci Rep; 2022 Sep; 12(1):15028. PubMed ID: 36056076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron Emission Tomography Imaging of Neurotensin Receptor-Positive Tumors with
    Renard E; Moreau M; Bellaye PS; Guillemin M; Collin B; Prignon A; Denat F; Goncalves V
    J Med Chem; 2021 Jun; 64(12):8564-8578. PubMed ID: 34107209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc.
    Nock BA; Nikolopoulou A; Reubi JC; Maes V; Conrath P; Tourwé D; Maina T
    J Med Chem; 2006 Jul; 49(15):4767-76. PubMed ID: 16854083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use.
    He T; Wang M; Wang H; Tan H; Tang Y; Smith E; Wu Z; Liao W; Hu S; Li Z
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2199-2207. PubMed ID: 31264168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F- and (68)Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1.
    Maschauer S; Einsiedel J; Hübner H; Gmeiner P; Prante O
    J Med Chem; 2016 Jul; 59(13):6480-92. PubMed ID: 27336295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
    Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O
    Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
    Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
    Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
    Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
    Wu Z; Li L; Liu S; Yakushijin F; Yakushijin K; Horne D; Conti PS; Li Z; Kandeel F; Shively JE
    J Nucl Med; 2014 Jul; 55(7):1178-84. PubMed ID: 24854793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor.
    Deng H; Wang H; Wang M; Li Z; Wu Z
    Mol Pharm; 2015 Aug; 12(8):3054-61. PubMed ID: 26162008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging Neurotensin Receptor in Prostate Cancer With
    Deng H; Wang H; Zhang H; Wang M; Giglio B; Ma X; Jiang G; Yuan H; Wu Z; Li Z
    Mol Imaging; 2017; 16():1536012117711369. PubMed ID: 28849698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New neurotensin analogue radiolabeled by 99m-technetium as a potential agent for tumor identification.
    Emrarian I; Sadeghzadeh N; Abedi SM; Abediankenari S
    Chem Biol Drug Des; 2018 Jan; 91(1):304-313. PubMed ID: 28816013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides.
    Schubiger PA; Allemann-Tannahill L; Egli A; Schibli R; Alberto R; Carrel-Rémy N; Willmann M; Bläuenstein P; Tourwé D
    Q J Nucl Med; 1999 Jun; 43(2):155-8. PubMed ID: 10429510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
    Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
    J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
    Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
    Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.